Important Safety Information|Prescribing Information|Health Care Professionals  

	An albumin-free recombinant factor VIII product that uses a state-of-the-art purification process.
	Talk to your health care provider to find out whether XYNTHA may be right for you.
	Need help paying for XYNTHA? Learn about the Patient Assistance Program.

Indication

•	XYNTHA™ Antihemophilic Factor (Recombinant), Plasma/Albumin-Free is indicated for the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A.
•	XYNTHA does not contain von Willebrand factor and, therefore, is not indicated in von Willebrand’s disease.

Important Safety Information

Please see full Prescribing Information

Important Safety Information|Prescribing Information

This site is intended only for residents of the United States.

Privacy Policy|Site Map|Contact Us|Terms & Conditions|Patient Assistance Program |Global Privacy Principles

249486-01© 2009, Wyeth Pharmaceuticals Inc., Philadelphia, PA 19101